FacebookXInstagramTelegram
WhatsApp! 020-122-280-6824

About Editorial team of BIPNs

Main team of content of bipns.com. Any type of content should be approved by us.
17 11, 2025

XRP, Chainlink & Cryptos – American Wrap 17 November

By |2025-11-17T21:40:18+02:00November 17, 2025|Crypto News, News|0 Comments

Ripple (XRP) is sending mixed signals, trading around $2.27 at the time of writing on Monday. The cross-border remittance has faced a series of declines and liquidations, leaving investors counting losses since its record high of $3.66 on July 18. 

Chainlink (LINK) is trading above $14.00 at the time of writing on Monday, as the broader cryptocurrency market mildly recovers following last week’s volatility and extended sell-off.

Bitcoin (BTC) offers subtle signs of recovery, trading above $95,000 at the time of writing on Monday. Altcoins, including Ethereum (ETH) and Ripple (XRP), are making recovery attempts, following in BTC’s footsteps, with ETH hovering below $3,200 and XRP trading around $2.27.

Source link

Read More
17 11, 2025

Tanning led to melanoma at a young age

By |2025-11-17T21:19:20+02:00November 17, 2025|Fitness News, News|0 Comments


As told to Erica Rimlinger

I used to be the person who showed up to the Christmas party every year bronzed and glowing with a fresh tan. A tan was part of my regular beauty routine, and I felt incomplete without one. I never dreamed I’d walk into my longtime tanning salon and cancel my membership, but that day arrived.

The cancellation form asked me to provide a reason. In big letters, I wrote: MELANOMA. I was 26 years old, newly diagnosed with one of the deadliest forms of skin cancer and furious with myself for ignoring the warnings in the small print of my contract. The salon employee looked at my completed form, said, “OK, you’re all set,” and walked away.

Earlier, my mom had urged me to get a mole on my chest checked. She was worried because my dad had been diagnosed with stage 0 melanoma the month before. I thought my dad’s diagnosis was understandably making her a little paranoid. Just five weeks after my 26th birthday, I was nowhere near my dad’s age, and my suspicious mole looked nothing like his. Mine wasn’t big like my dad’s mole — but it was multi-colored with uneven edges.

I dismissed her with a “Sure, Mom,” but her worry lodged in my brain. I went down a Google rabbit hole and looked at too many pictures of suspicious moles. I finally thought, OK, it wouldn’t hurt to get a skin check with a dermatologist.

I was a little unprepared for the experience of standing naked, head to toe, in front of a doctor I’d met five seconds earlier. I have a lot of moles, and as the doctor inspected them, he asked about my tanning bed use, family history of melanoma and sun habits. I started to feel uncomfortable and a little defensive. I live in Ohio where we don’t get much sun, and a tan is a beauty standard. You wouldn’t see a model without a tan, right? The doctor asked if I had any moles that concerned me. Stubbornly, I said no.

2019

He zoomed in on the one my mom disliked, however. It didn’t look like the rest of my moles. He removed it for a biopsy, and I thought, “Great. All done.” I’d heard of people getting pre-cancerous moles removed all the time. It didn’t mean anything bad was happening. My mom would be happy I got my skin check, and I admit I felt a little better too.

The doctor said I’d get the results in three to five business days, but after 10 days I’d heard nothing. I called the medical office and asked if they’d lost my mole. The medical team apologized and said they’d sent it out for additional testing. That’s when I felt the first negative vibe.

On the 14th business day after the biopsy, I was in the car with my husband when the dermatologist office called with my results. The grim tone of my doctor’s voice announced the melanoma before the word was even spoken. Thank goodness my husband was driving. I had stage 1a, bordering on 1b, melanoma. My first thought was, “This is worse than my dad’s.” Then I thought, “How could this be worse than my dad’s?” The doctor recommended immediate surgery and a lymph node test. The entire call lasted less than 10 minutes, but it had stripped all the color from my face and my world.

Two weeks after that phone call, I checked in to the hospital for an eight-hour day. I’d never had anesthesia before. The only medical procedure I’d had was my wisdom teeth removal. I woke up from surgery with two big incisions and a wave of grief for the life I didn’t have anymore. I didn’t just enjoy being tan. Tanning was rooted deeply in my body image. In addition to grief, I also felt anger with myself, with the sun, and even with my dad’s habit of getting sunburned mowing the lawn or playing golf.

I wanted to run, lift weights and lay out in the sun again. The first two desires would have to wait until I healed, and the third was no longer an option for me. I’d have to change my lifestyle — and cancel my tanning salon membership.

I ended my pity party after about a month and a half. I realized it was getting me nowhere, and I was being given an opportunity to learn, change my habits and appreciate my second chance. But I’d do this quietly, telling almost no one because of the shame I felt about my diagnosis.

Tanning led to melanoma at a young age 2024

For the next two years after my surgery, I got frequent skin checks and more biopsies than I could count. My whole body felt like it was being sliced up. Under the weight of the mental, emotional and physical burden of survivorship, I realized I needed support. It was time to share my story.

On social media, I found #melanoma and was stunned to see how many young people in their 20s were sharing their melanoma stories. I took a picture of my scars, posted it, then panicked and threw the phone across the room.

The scorn, shame and “told you so” messages I expected never appeared — not even once. My community gave me love and support instead, and I was so grateful. Once I started connecting with other melanoma survivors and advocates, my burden lifted.

I’m glad I reached out for support when I did. My dad’s melanoma returned in his brain and lungs. After 21 rounds of immunotherapy, gamma knife radiation and multiple trips to the emergency room, my dad’s lesions began shrinking. Today, my dad is still here, and his melanoma is almost gone. We’re so grateful, and this experience has brought our family much closer together.

Leah and her father at her wedding, June 2025 Leah and her father at her wedding, June 2025. (Photo/Aisley Herndon)

I now own my sun-loving past. Instead of silently shaming myself, I speak up and advocate for sun care and skin checks. I serve as a volunteer for Melanoma Research Foundation, and I’m on the leadership committee for Melanoma Research Alliance (MRA). For MRA, I go to Capitol Hill every year, urging Congress to protect research funding, ban tanning beds and investigate better sunscreen ingredients.

Instead of beating myself up for neglecting sun safety as a teen and young adult, I’m working to change the culture that encourages people to ignore the risks of tanning. I still show up to Christmas parties glowing — but with gratitude, not a tan.

This educational resource was created with support from Merck.

Have your own Real Women, Real Stories you want to share? Let us know.

Our Real Women, Real Stories are the authentic experiences of real-life women. The views, opinions and experiences shared in these stories are not endorsed by HealthyWomen and do not necessarily reflect the official policy or position of HealthyWomen.

From Your Site Articles

Related Articles Around the Web



Source link

Read More
17 11, 2025

XAU/USD in wait-and-see mode below $4,100

By |2025-11-17T20:13:25+02:00November 17, 2025|Forex News, News|0 Comments


XAU/USD Current price: $4,075.18

  • Speculative interest awaits earnings reports and US macroeconomic updates.
  • The odds for a Federal Reserve no change in December stand above 55%.
  • XAU/USD turned neutral, with the bearish potential limited despite the latest slide.

Spot Gold trades with a soft tone on Monday, although confined to a well-limited intraday range. The bright metal hovers around $4,070 a troy ounce in the American session, trading at the lower end of Friday’s range, as investors await fresh clues about the United States (US) economic health.

The US Dollar (USD) is mixed across the FX board, but stable, as investors await the release of US figures delayed by the government shutdown. Among other things, the Building Permits, Housing Starts, and Goods Trade balance will be released on Wednesday, while the country will publish the September Nonfarm Payrolls (NFP) report on Thursday.

US data will be critical ahead of the US Federal Reserve (Fed) monetary policy meeting in mid-December. The central bank trimmed the benchmark interest rate in October, but raised doubts about a similar movement in December. Currently, the odds of an on-hold decision are above 55%. Such a picture could change once speculative interest assesses fresh macro data.

Other than that, the earnings season kicks in: Several tech-related companies will report in the upcoming days, including the AI giant NVIDIA. As a result, Wall Street is also in a wait-and-see mode, with the three major indexes trading mixed, yet not far from their daily opening levels.

XAU/USD short-term technical outlook

XAU/USD trades at $4,075.18, and the 4-hour chart shows the risk skews to the downside, although chances of a steeper decline seem limited. The pair is trading below a bearish 20-period Simple Moving Average (SMA), currently at $4,144, but holds above the 100 and 200 SMAs, signaling a near-term correction against a still positive longer-term slope. At the same time, the Momentum indicator and the Relative Strength Index (RSI) indicator both hold within negative levels, although aiming marginally higher, suggesting limited selling interest. A break below the 100-period SMA at $4,043.20 should hint at a steeper decline, while a close above the 20-period SMA at $4,144.05 would lift the bias back to the upside.

In the daily chart, XAU/USD is correcting lower, but it is far from being bearish. The 20-day SMA has turned lower but remains above the rising 100- and 200-day SMAs, while the pair continues to develop above them. The 20-day SMA at $4,051.62 offers nearby dynamic support. At the same time, the Momentum stands above its midline and rising, while the RSI eases at around 53 (neutral), hinting at a slower upside pace.

(The technical analysis of this story was written with the help of an AI tool)



Source link

Read More
17 11, 2025

Berberine API Market to Reach USD 973.13 Million by 2034,

By |2025-11-17T19:45:20+02:00November 17, 2025|Dietary Supplements News, News|0 Comments


Ottawa, Nov. 17, 2025 (GLOBE NEWSWIRE) — The global berberine API market size was valued at USD 523 million in 2024 and is predicted to hit around USD 973.13 million by 2034, rising at a 6.45% CAGR, a study published by Towards Healthcare a sister firm of Precedence Research. The global berberine API market is driven by the expanding healthcare applications and growing innovations.

The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ https://www.towardshealthcare.com/download-sample/6313

Key Takeaways

  • Asia Pacific held a major revenue of 68% share of the market in 2024.
  • North America is expected to witness the fastest growth in the berberine API market during the forecast period.
  • By product grade/quality, the nutraceutical/dietary-supplement grade segment held a major revenue of 58% share of the market in 2024.
  • By product grade/quality, the custom/formulation-ready premixes & blends segment is expected to witness the fastest growth in the market from 2025 to 2034.
  • By source/manufacturing route, the plant-extracted segment held a major revenue of 72% share of the market in 2024.
  • By source/manufacturing route, the semi-synthetic/synthetic segment is expected to witness the fastest growth in the market from 2025 to 2034.
  • By form/salt type offered, the berberine chloride/berberine HCl segment held a major revenue of 62% share of the market in 2024.
  • By form/salt type offered, the micronized/particle-engineered berberine segment is expected to witness the fastest growth in the market from 2025 to 2034.
  • By application/end use, the dietary supplements & nutraceuticals segment held a major revenue of 60% share of the market in 2024.
  • By application/end use, the pharmaceutical/prescription products segment is expected to witness the fastest growth in the market from 2025 to 2034.
  • By business model/sales channel, the bulk API sales to formulators/brand owners segment held a major revenue of 55% share of the market in 2024.
  • By business model/sales channel, the direct-to-brand white-label & co-packing segment is expected to witness the fastest growth in the market from 2025 to 2034.

What is the Berberine API?

The berberine API market is driven by increasing consumer interest in natural remedies for the management of chronic diseases and growing dietary supplement applications. The berberine API refers to the concentrated form of berberine alkaloids, which are used in the development of dietary supplements or pharmaceutical products. They are used to improve insulin sensitivity, lipid profiles, cardiovascular health, and gut health.

Executive Summary Table

Table Scope
Market Size in 2025 USD 556.74 Million
Projected Market Size in 2034 USD 973.13 Million
CAGR (2025 – 2034) 6.45 %
Leading Region North America by 68%
Market Segmentation By Product Grade / Quality, By Source / Manufacturing Route, By Form / Salt Type Offered, By Application / End Use, By Business Model / Sales Channel, By Region
Top Key Players Spectrum Chemical / Spectrum Nutraceuticals, Ningbo / Zhejiang regional botanical extract manufacturers, Hunan / Anhui botanical extract suppliers, Nutraceutical API trading houses & distributors, AdvanSix, Contract API CDMOs, Sabinsa-style formulators, Lonza / Catalent / other large CDMOs, Nutraceutical brand, Botanical farms, Natural ingredient brokers

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

What are the Major Growth Drivers in the Berberine API Market?

Growing metabolic disease is the major driver in the market. This is increasing the demand for natural or plant-based treatment options for their management, increasing their use. Additionally, expanding the nutraceutical sector, technological innovations, and increasing sustainability trends are some of the other market drivers.

What are the Key Drifts in the Berberine API Market?

The market has been expanding due to the growing collaborations to launch and enhance the use of various berberine solutions.

  • In October 2025, a collaboration between Gencor and Pharmako Biotechnologies launched BioBerb, which is a cold-water dispersible berberine at SupplySide Global, held in Las Vegas.
  • In March 2025, an Access and Benefit Sharing (ABS) agreement was signed between Himachal Pradesh Department of Biodiversity and Botanic Healthcare, which is a leader in the nutraceutical sector, committed to sustainability by ethically producing and sourcing Berberis aristata (Kashmal).

What is the Significant Challenge in the Berberine API Market?

Quality and standardization issues act as the major challenge in the market. This may affect the purity, quality, and effectiveness of the products, decreasing their acceptance rates. Moreover, poor bioavailability, drug interactions, competition from synthetic alternatives, and regulatory challenges act as other market limitations.

Regional Analysis

Berberine API Market to Reach USD 973.13 Million by 2034,

Why did Asia Pacific Dominate the Berberine API Market in 2024?

In 2024, the Asia Pacific captured the biggest revenue share of 68% in the market, due to its long history as a traditional medicine. They were used for the treatment of diabetes, metabolic disorders, and as dietary supplements, where the growing awareness also increased their use as nutraceuticals. This increased their production rates as well as innovations, which were backed by investments. This contributed to the market growth.

What Made North America the Fastest Growing Region in the Berberine API Market in 2024?

North America is expected to host the fastest growth in the market during the forecast period, due to the presence of a robust supply market. The growing consumer awareness is also increasing their use as preventive and natural health products. The growing diseases and R&D are also increasing their demand and innovations, where their availability is being enhanced through online platforms, which is promoting the market growth.

Become a valued research partner with us – https://www.towardshealthcare.com/schedule-meeting

Segmental Insights

By product grade/quality analysis

Why Did the Nutraceutical/Dietary-Supplement Grade Segment Dominate in the Berberine API Market in 2024?

By product grade/quality, the nutraceutical/dietary-supplement grade segment led the market with 58% share in 2024, as they were used as natural products for weight management as well as metabolic health. They were affordable and easily accessible, which increased their use.

By product grade/quality, the custom/formulation-ready premixes & blends segment is expected to show the fastest growth rate in the market from 2025 to 2034, due to their improved bioavailability. The ready-use blend saves time and contains multi-ingredient formulations, which is increasing their acceptance rates.

By source/manufacturing route analysis

Which Source/Manufacturing Route Type Segment Held the Dominating Share of the Berberine API Market in 2024? 

By source/manufacturing route, the plant-extracted segment held the dominating share of 72% in the market in 2024, driven by its traditional medicinal use. Moreover, as they are naturally occurring and consist of target alkaloids, their use has increased, driving their production and cultivation.

By source/manufacturing route, the semi-synthetic/synthetic segment is expected to show the highest growth in the market from 2025 to 2034, due to its better standardization and purity. They are easy to scale up, and new novel analogues or delivery systems can be easily developed to enhance their applications.

By form/salt type offered analysis

What Made Berberine Chloride/Berberine HCl the Dominant Segment in the Berberine API Market in 2024?

By form/salt type offered, the berberine chloride/berberine HCl held the largest share of 62% in the market in 2024, driven by its better water solubility. Additionally, they also provided accurate dosing, which increased their use in the forms of tablets, capsules, and other nutraceutical formulations.

By form/salt type offered, the micronized/particle-engineered berberine segment is expected to show the fastest growth rate in the market from 2025 to 2034, due to its enhanced bioavailability. This is increasing their use as fast-acting health products, driving their demand in nutraceuticals.

Get the latest insights on life science industry segmentation with our Annual Membership: https://www.towardshealthcare.com/get-an-annual-membership

By application/end use analysis

How the Dietary Supplements & Nutraceuticals Segment Dominated the Berberine API Market in 2024?

By application/end use, the dietary supplements & nutraceuticals segment led the market with 60% share in 2024, due to its increased use in blood sugar control and weight management. They were also used as natural products, where their increased availability prompted their use.

By application/end use, the pharmaceutical/prescription products segment is expected to show the highest growth in the market from 2025 to 2034, due to their increasing R&D. They are also being formulated for the treatment of diabetes and lipid disorders, which is increasing their acceptance rates.

By business model/sales channel analysis

Which Business Model/Sales Channel Type Segment Held the Dominating Share of the Berberine API Market in 2024? 

By business model/sales channel, the bulk API sales to formulators/brand owners segment held the dominating share of 55% the market in 2024, due to their focus on product development. Therefore, the large-scale production helped in producing affordable berberine solutions, which increased their use.

By business model/sales channel, the direct-to-brand white-label & co-packing segment is expected to show the fastest growth rate in the market from 2025 to 2034, due to its low upfront investments and faster product launches. Moreover, their flexibility provides varied batch sizes, which is increasing their use.

Recent Developments in the Berberine API Market

  • In August 2025, Metaberine, a green process-enriched berberine, was developed with the use of BioSOLVE Technology, which was launched by Zeus Hygia Lifesciences, a leader in nutraceutical solutions.

Browse More Insights of Towards Healthcare:

The global insulin API market size is calculated at US$ 4.51 billion in 2025, grew to US$ 4.94 billion in 2026, and is projected to reach around US$ 10.21 billion by 2034. The market is expanding at a CAGR of 9.52% between 2024 and 2034.

The global oncology API market size is calculated at USD 41.79 billion in 2024, grew to USD 43.95 billion in 2025, and is projected to reach around USD 69.55 billion by 2034. The market is expanding at a CAGR of 5.24% between 2025 and 2034.

The global steroid hormone API market size is calculated at US$ 3.54 billion in 2024, grew to US$ 3.74 billion in 2025, and is projected to reach around US$ 6.06 billion by 2034. The market is expanding at a CAGR of 5.54% between 2025 and 2034.

The global small molecule API market size is calculated at US$ 206.9 billion in 2025, grew to US$ 219.52 billion in 2026, and is projected to reach around US$ 374.03 billion by 2035. The market is expanding at a CAGR of 6.1% between 2026 and 2035.

The global serum gonadotrophin API market size was estimated at US$ 131 million in 2024, projected to increase to US$ 137.1 million in 2025 and reach US$ 202.93 million by 2034, showing a healthy CAGR of 4.64% across the forecast years.

The global non-ionic contrast media API market size is calculated at US$ 1.81 billion in 2024, grew to US$ 1.92 billion in 2025, and is projected to reach around US$ 3.32 billion by 2034. The market is projected to expand at a CAGR of 6.34% between 2025 and 2034.

The clavulanic acid series API market was estimated at US$ 385 million in 2023 and is projected to grow to US$ 777.66 million by 2034, rising at a compound annual growth rate (CAGR) of 6.6% from 2024 to 2034.

Berberine API Market Key Players List

  • Hunan/Anhui botanical extract suppliers
  • Spectrum Chemical/Spectrum Nutraceuticals
  • AdvanSix
  • Ningbo/Zhejiang regional botanical extract manufacturers
  • Sabinsa-style formulators
  • Nutraceutical API trading houses & distributors
  • Botanical farms
  • Contract API CDMOs
  • Lonza/Catalent/other large CDMOs
  • Natural ingredient brokers
  • Nutraceutical brand

Segments Covered in The Report

By Product Grade/Quality

  • Nutraceutical/Dietary-Supplement Grade
  • standard extract powders
  • Pharmaceutical / GMP API Grade
  • Research/Analytical Standards
  • Custom/Formulation-ready Premixes & Blends

By Source/Manufacturing Route

  • Plant-extracted
  • Semi-synthetic/Synthetic
  • Biotechnological / Fermentation routes
  • Blends & standardized extracts

By Form/Salt Type Offered

  • Berberine chloride/berberine HCl
  • Berberine sulfate / free base
  • Micronized/particle-engineered berberine
  • Encapsulated/coated API premixes for direct fill

By Application/End Use

  • Dietary Supplements & Nutraceuticals
  • Functional Foods & Beverages
  • Pharmaceuticals/Prescription Products
  • Cosmeceuticals & OTC topical uses
  • Research, clinical trials & CRO supplies
  • Veterinary formulations

By Business Model/Sales Channel

  • Bulk API Sales to Formulators/Brand Owners 
  • Toll-manufacturing / private-label supply
  • Packaged ingredient (premixes, blends) sales
  • Direct-to-brand white-label & co-packing
  • Distributor/trading house resale

By Region

North America 

  • U.S. 
  • Canada 
  • Mexico 
  • Rest of North America 

 South America 

  • Brazil 
  • Argentina 
  • Rest of South America 

Europe 

  • Western Europe  
    • Germany 
    • Italy 
    • France 
    • Netherlands 
    • Spain 
    • Portugal 
    • Belgium 
    • Ireland 
    • UK 
    • Iceland 
    • Switzerland 
    • Poland 
    • Rest of Western Europe 
  • Eastern Europe  
  • Austria 
  • Russia & Belarus 
  • Türkiye 
  • Albania 
  • Rest of Eastern Europe 

Asia Pacific

  • China 
  • Taiwan 
  • India 
  • Japan 
  • Australia and New Zealand,  
  • ASEAN Countries (Singapore, Malaysia) 
  • South Korea 
  • Rest of APAC 

 MEA 

  • GCC Countries 
  • Saudi Arabia 
  • United Arab Emirates (UAE) 
  • Qatar 
  • Kuwait 
  • Oman 
  • Bahrain 
  • South Africa 
  • Egypt 
  • Rest of MEA 

Immediate Delivery Available | Buy This Premium Research @ https://www.towardshealthcare.com/checkout/6313

Access our exclusive, data-rich dashboard dedicated to the healthcare market – built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.

Access the Dashboard: https://www.towardshealthcare.com/access-dashboard

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth.

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

Europe Region: +44 778 256 0738

North America Region: +1 8044 4193 44

APAC Region: +91 9356 9282 04

Web: https://www.towardshealthcare.com

Our Trusted Data Partners

Precedence Research | Statifacts | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire | Nutraceuticals Func Foods | Onco Quant | Sustainability Quant | Specialty Chemicals Analytics

Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | Pinterest



Source link

Read More
17 11, 2025

Solana Price Prediction: Investors Are Ditching XRP for SOL – Are Institutions Quietly Choosing Sides?

By |2025-11-17T19:39:17+02:00November 17, 2025|Crypto News, News|0 Comments

Speaking at The Bridge conference in New York City, Bassili noted that while Solana is not yet universally accepted as the definitive “third asset”, it is clearly the one most institutions are evaluating.

Despite posting impressive gains this year, XRP still lags behind in key metrics that matter most to institutions, particularly network velocity and active liquidity participation.


According to Bassili, without strong signals of real-world usage, major investors are unlikely to elevate XRP into the top 3.

SOL Price Analysis: $300 Target Next?

As per the chart below, Solana is cooling down after a brief corrective phase, with current price action focused around the $142–$145 range.

SOL recently broke through a short-term descending trendline as well while buyers defended the lower support band shown in green.

If SOL breaks above $150, the next level to keep an eye on is the broader resistance cluster between $185 and $200.

Should bulls clear this red zone decisively, the next target is the $300 region, a potential 110% surge from current levels.

Source: TradingView

Notably, the Relative Strength Index (RSI) is recovering from oversold levels and the MACD is giving early signs of trend reversal.

Investors can expect SOL to turn volatile in the short term.

Preference for SOL

Bassili said that institutions are not merely following narratives but they are following data.

Solana’s expanding ecosystem activity, liquidity depth, and improving market structure make it lucrative while XRPL has yet to show similar strength.

Solana Speed Meets Bitcoin Security as $HYPER Presale Explodes Past $27 Million

While Solana prepares for a major breakout, Bitcoin Hyper ($HYPER) is bringing its speed and low fees to the world of Bitcoin.

This new Layer-2 solution uses the same powerful tech that powers Solana apps, allowing Bitcoin holders to send transactions in seconds, pay almost no fees, and access a whole new world of crypto apps.

Solana Price Prediction: Investors Are Ditching XRP for SOL – Are Institutions Quietly Choosing Sides?

Bitcoin Hyper keeps Bitcoin’s rock-solid security intact while solving its biggest problems, like slow speeds and limited utility.

Now, users can trade, stake, earn yield, and even mint NFTs without leaving the Bitcoin ecosystem.

So far, $27.8 million has poured into the presale, and the current token price is just $0.01325. The next increase hits in a few hours.

Early buyers can also stake $HYPER for up to 41% annual rewards.

To grab $HYPER at its current price, just head to the official Bitcoin Hyper website and connect a wallet like Best Wallet.

You can complete the purchase in seconds using crypto already in your wallet or simply pay with a debit or credit card.

Disclaimer: Coinspeaker is committed to providing unbiased and transparent reporting. This article aims to deliver accurate and timely information but should not be taken as financial or investment advice. Since market conditions can change rapidly, we encourage you to verify information on your own and consult with a professional before making any decisions based on this content.

Solana (SOL) News, Market News

Parth Dubey

A crypto journalist with over 5 years of experience in the industry, Parth has worked with major media outlets in the crypto and finance world, gathering experience and expertise in the space after surviving bear and bull markets over the years. Parth is also an author of 4 self-published books.

Parth Dubey on LinkedIn


Source link

Read More
17 11, 2025

US Dollar Forecast: Dollar Firms as Fed Cuts Fade, GBP/USD and EUR/USD Outlook

By |2025-11-17T17:57:17+02:00November 17, 2025|Forex News, News|0 Comments

At the same time, Treasury yields slipped, with the 2-year at 3.60% and the 10-year at 4.14%, signaling a more cautious bond market.

Fed Signals Reinforce Reduced Easing Expectations

The CME FedWatch Tool now shows a 46% probability of a 25-basis-point cut in December, down from 67% a week earlier. This adjustment follows a series of measured comments from Federal Reserve officials.

Kansas City Fed President Jeffrey Schmid said policy should continue to “lean against demand growth,” describing current rates as “modestly restrictive.” St. Louis Fed President Alberto Musalem added that rates are now closer to neutral, cautioning that there is limited room to ease without creating broader risks.

These remarks have tempered expectations for rapid policy shifts and kept investors hesitant to price in earlier cuts.

Market Awaits Delayed US Economic Releases

Attention is now turning to upcoming US data releases delayed by the recent government shutdown. The September Nonfarm Payrolls report is due on November 20, but gaps remain for several October indicators.

National Economic Council Director Kevin Hassett cautioned that some October data may not be recoverable, leaving markets waiting for clearer signals on the Fed’s next steps.

Source link

Read More
17 11, 2025

Europe Tea Market Analysis Report 2025-2033: Trends,

By |2025-11-17T17:44:23+02:00November 17, 2025|Dietary Supplements News, News|0 Comments


Dublin, Nov. 17, 2025 (GLOBE NEWSWIRE) — The “Europe Tea Market Analysis and Growth Forecast 2025-2033” has been added to ResearchAndMarkets.com’s offering.

The Europe Tea Market is anticipated to grow from US$ 20 billion in 2024 to US$ 33.71 billion by 2033 at a CAGR of 5.97% from 2025 to 2033. Growing health consciousness, demand for specialty and herbal teas, and changing consumer tastes towards organic products are fueling market expansion throughout the region, complemented by robust retail and e-commerce distribution networks.

Growth Drivers in the Europe Tea Market

Increased Health and Wellness Awareness

European consumers are increasingly substituting tea for sugary drinks and coffee as a healthier option. Green tea, herbal teas, and functional teas (which contain ingredients such as turmeric or ginger) are becoming sought after for their antioxidant, cleansing, and soothing virtues. As interest grows in immune well-being and mental health, demand for organic and wellness-focused tea products has accelerated, particularly since COVID-19, transforming consumption behaviors throughout the region. March 2024, Twinings launched a line of functional tea blends specially crafted for the European market, featuring distinctive botanical ingredients and wellbeing benefits.

Growth in Specialty and Premium Tea

The tea market in Europe is being driven by growth in specialty blends, luxury teas, and artisanal products. Consumers are trying new tastes, single-origin teas, and responsibly sourced varieties, stimulating innovation among companies. Boutique tea houses, experience-based store formats, and edited subscription boxes are raising tea from an ordinary drink to an aspirational product. The premiumization movement has widened appeal across younger, more upscale audiences. January 2024, Unilever PLC introduced a new range of premium organic teas appealing to health-focused consumers, with innovative eco-friendly packaging.

Development of E-commerce and Digital Retail Channels

Online tea sales have seen high growth in Europe as a result of convenience, wider product range, and social media. Internet platforms enable access to niche and international brands that might be lacking in physical retail. Subscription models and wellness influencers also play a part in product finding and interaction, enabling tea businesses to create direct customer relationships and tailor offers. For instance, in the UK, tea sales online became extremely popular, with investment increasing by 70% in 2022, according to the British E-commerce Association. One of the main forces driving this sector’s high growth is the increasing focus on digital accessibility and subscription services.

Challenges in the Europe Tea Market

Market Saturation and Intense Competition

The European tea industry is mature and competitive, especially in Western Europe. There are many local and international brands competing for consumers’ attention, triggering price pressure and constrained shelf space. Innovation assists but is challenging for new brands to make headway without massive marketing spend. Mature tea-consuming nations such as the UK experience levelling-off growth, with brands needing to differentiate via health messages, taste, or ethical origin.

Fluctuating Raw Material Costs and Climate Impact

Tea production is greatly dependent on climatic factors. Erratic weather conditions, floods, and droughts in key tea-producing countries such as India, Sri Lanka, and Kenya may impact supply chains and raise costs. These uncertainties impact price and supply in Europe. Also, increased transportation and energy costs, along with sustainability issues, pose difficulties for producers and importers in keeping the producers profitable without sacrificing quality or ethical sourcing practices.

Key Attributes

Report Attribute Details
No. of Pages 200
Forecast Period 2024-2033
Estimated Market Value (USD) in 2024 $20 Billion
Forecasted Market Value (USD) by 2033 $33.71 Billion
Compound Annual Growth Rate 5.9%
Regions Covered Europe

Key Topics Covered

1. Introduction

2. Research & Methodology

3. Executive Summary

4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges

5. Europe Tea Market
5.1 Historical Market Trends
5.2 Market Forecast

6. Market Share Analysis
6.1 By Product Type
6.2 By Packaging
6.3 By Application
6.4 By Distribution Channel
6.5 By Country

7. Product Type
7.1 Green Tea
7.2 Black Tea
7.3 Oolong Tea
7.4 Others

8. Packaging
8.1 Plastic Containers
8.2 Loose Tea
8.3 Paper Boards
8.4 Aluminium Tea
8.5 Tea Bags
8.6 Others

9. Application
9.1 Residential
9.2 Commercial

10. Distribution Channel
10.1 Supermarkets and Hypermarkets
10.2 Specialty Stores
10.3 Convenience Stores
10.4 Online Stores
10.5 Others

11. Country
11.1 France
11.2 Germany
11.3 Italy
11.4 Spain
11.5 United Kingdom
11.6 Belgium
11.7 Netherlands
11.8 Russia
11.9 Poland
11.10 Greece
11.11 Norway
11.12 Romania
11.13 Portugal
11.14 Rest of Europe

12. Value Chain Analysis

13. Porter’s Five Forces Analysis
13.1 Bargaining Power of Buyers
13.2 Bargaining Power of Suppliers
13.3 Degree of Competition
13.4 Threat of New Entrants
13.5 Threat of Substitutes

14. SWOT Analysis
14.1 Strength
14.2 Weakness
14.3 Opportunity
14.4 Threats

15. Pricing Benchmark Analysis

16. Key Players Analysis
16.1 Associated British Foods PLC
16.2 Tata Consumer Products Limited (Tata Group)
16.3 Unilever
16.4 Barry’s Tea
16.5 Taetea Group

For more information about this report visit https://www.researchandmarkets.com/r/o6nc6w

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.



Source link

Read More
17 11, 2025

Ethereum Price Prediction Sounds Alarm on Bear Channel

By |2025-11-17T17:38:35+02:00November 17, 2025|Crypto News, News|0 Comments

That’s it. I’m done. I’m done with crypto. Lamest bull market of my life. didn’t even make it to 150k. Tom Lee’s Ethereum price prediction was wrong, and ETH made a new ATH for all of two seconds. There was no alt season.

And the only coins that did anything notable were flagrant casino 1000x tokens. Future of finance my ass.

Meanwhile, Ether cracked below the $3,100 level for the first time since early November, slipping to $3,066 on Sunday during a broader crypto pullback.

The drop came alongside a surge in ETF redemptions and growing concerns that Ethereum is becoming the “risk-on” trade of the sector. So what’s going on with Ethereum? Is it dying?

DISCOVER: 20+ Next Crypto to Explode in 2025

Investment manager Timothy Peterson highlighted a worrying trend that isn’t visible in headline ETF flows.

“Spot ether ETFs posted net outflows in four of the past five weeks, totaling roughly 7 percent of cost-basis capital,” Peterson said.

Cost-basis withdrawals track how much of the original capital committed to an ETF is leaving and it isn’t look good for Ethereum. Rising redemptions here show conviction weakening among long-term holders, not just traders repositioning.

It leaves our Ethereum price prediction showing that the price will not be near the ATH again for the rest of 2025. Not good.

DISCOVER: Next 1000X Crypto: 10+ Crypto Tokens That Can Hit 1000x in 2025

A sweep across key analytics platforms adds more context to the ETH price:

  • CoinGecko: Ether down 11 percent in 24 hours

  • DeFi Llama: ETH TVL fell 2.1 percent this week, reversing prior gains

  • FRED (Rates): Long-term yields remain elevated, restraining risk assets

Despite the volatility, ETH still trades comfortably above its 200-day moving average near $2,550, a level that has historically defined cycle support zones.

Ethereum’s 4-hour chart shows price locked inside a narrowing falling wedge, which is a corrective pattern that often precedes upside breaks. ETH has repeatedly been rejected at the upper trendline and the stacked supply zones near $3,550 and $3,800.

A decisive reclaim of $3,350 will flip the short-term trend and open a path back toward $3,550. Failure keeps the wedge intact and elevates the risk of a $3,000 retest or even a quick liquidity sweep below it before any true reversal.

Ether slipping under $3,100 says more than a bad trading day. ETF outflows, shaky macro signals, and stubborn resistance have all piled onto the chart at the same time.

Source link

Read More
17 11, 2025

DeFi Technologies Announces Leadership Transition: Olivier Roussy Newton Resigns as CEO and Chairman; Co-Founder Johan Wattenström Appointed as Successor | Corporate

By |2025-11-17T16:17:18+02:00November 17, 2025|News, NFT News|0 Comments


DeFi Technologies Inc.

/ Key word(s): Personnel

DeFi Technologies Announces Leadership Transition: Olivier Roussy Newton Resigns as CEO and Chairman; Co-Founder Johan Wattenström Appointed as Successor

17.11.2025 / 14:10 CET/CEST
The issuer is solely responsible for the content of this announcement.

TORONTO, Nov. 17, 2025 /PRNewswire/ — DeFi Technologies Inc. (the “Company” or “DeFi Technologies“) (Nasdaq: DEFT) (CBOE CA: DEFI) (GR: R9B), a financial technology company bridging the gap between traditional capital markets and decentralized finance  (“DeFi”), today announced that Olivier Roussy Newton has resigned as Chief Executive Officer and Executive Chairman of the Board. The Company’s Board of Directors has appointed Johan Wattenström, Co-Founder of Valour and DeFi Technologies, as Chief Executive Officer and Executive Chairman effective upon Mr. Roussy Newton’s departure. Mr. Roussy Newton will be appointed Strategic Advisor of the Company beginning in December.

After founding Valour Inc. with Mr. Wattenström nearly a decade ago, Mr. Roussy Newton was appointed CEO of DeFi Technologies on October 6, 2022, during one of the most severe bear markets in crypto history. At that time, the Company’s shares traded at approximately $0.5, and it reported year-end 2022 cash of approximately $3.4 million and loans payable of approximately $37.6 million. Over the last three years under Mr. Roussy Newton’s leadership, DeFi Technologies scaled Valour’s ETP platform, executed strategic M&A, strengthened its balance sheet, and cemented its position as a leader in the digital asset industry through innovation, execution, growth, and profitability.

“I am proud of what our team has delivered over the past three years. We scaled and institutionalized Valour’s ETP platform, strengthened our capital base, executed strategic M&A, and delivered record financial results for our shareholders,” said Mr. Roussy Newton. “I’m deeply grateful for the support of our employees, partners, and investors, and am confident that Johan, having been by my side since the inception of the company, is the right person to lead DeFi Technologies through its next phase of growth.”

Highlights under Mr. Roussy Newton’s leadership

  • Expanded ETP platform to 100 listed products with more than US$1 billion in assets under management, broadening investor access to digital assets across major European exchanges.
  • Uplisted to the Nasdaq Capital Market under ticker DEFT and subsequently commenced options trading on Nasdaq, increasing visibility and access for U.S. investors.
  • Accelerated revenue expansion, including scaling DeFi’s revenues from $4.5 million in 2021 to more than $50 million in 2024. Under Olivier’s most recent year as CEO, DeFi has generated over $80 million year-to-date and is on track to deliver its first $100-million-plus revenue year.
  • Debt reduction and financial flexibility, including the full repayment of outstanding debt at Valour, significantly improving the asset-management subsidiary’s financial profile and flexibility.
  • Strategic M&A and diversification, including the acquisition of Stillman Digital, a global digital-asset liquidity provider and OTC desk that enhances trading, market making, and institutional capabilities.
  • Organizational depth, with key executive hires across asset management, trading, technology, and capital markets that support continued expansion and governance.
  • Index inclusions and market transparency initiatives, including additions to widely followed indices and the adoption of third-party tools to enhance trading surveillance and shareholder intelligence.
  • Strengthened the balance sheet, including a registered direct offering of approximately $100 million led by strategic, blue-chip institutions to pursue further digital asset expansion, lending and staking transactions, provide funds for potential acquisition opportunities and fund recently announced business initiatives that align with its growth strategy.

Leadership Succession

The Board of Directors has appointed Johan Wattenström, Co-Founder of DeFi Technologies, as Chief Executive Officer and Executive Chairman.

Mr. Wattenström is a seasoned entrepreneur and executive with nearly two decades of experience at the intersection of digital assets, trading, and financial infrastructure. He co-founded Valour, DeFi’s European ETP platform, and has been instrumental in shaping the Company’s product strategy, trading architecture, and global exchange relationships since inception.

Prior to DeFi Technologies, Mr. Wattenström founded and served as CEO of XBT Provider, the issuer of the world’s first Bitcoin ETP, which quickly surpassed $1 billion in assets under management and became one of Europe’s most relied-upon regulated on-ramps to crypto before its acquisition by CoinShares. His work establishing secure, exchange-listed Bitcoin exposure set the template for how institutions first entered digital assets and remains a foundational milestone for the industry today.

Mr. Wattenström also previously founded Nortide Capital, a global digital-asset trading and market-making firm, which provides liquidity and structured solutions to some of the world’s largest exchanges and token issuers. His combined experience across product structuring, market-making, and institutional trading uniquely positions him to lead DeFi Technologies into its next phase of growth.

“Olivier and I have built this company together from the ground up,” said Mr. Wattenström. “I’m grateful for his leadership and friendship, and I look forward to leading DeFi Technologies into its next phase of growth. We will continue to scale our ETP platform globally, expand our trading operations both internally and through Stillman Digital, and continue to bridge traditional capital markets with the digital asset ecosystem.”

Following the transition, Mr. Roussy Newton will be a strategic advisor to the Company and remain a cornerstone shareholder of the Company, ensuring continuity of vision and execution as DeFi Technologies enters its next stage of expansion. He is also deeply focused on strengthening the bridge between DeFi Technologies and BTQ Technologies, leveraging BTQ’s quantum-secure infrastructure to enhance the resilience, security, and long-term competitiveness of DeFi’s product ecosystem.

About DeFi Technologies

DeFi Technologies Inc. (Nasdaq: DEFT) (CBOE CA: DEFI) (GR: R9B) is a financial technology company bridging the gap between traditional capital markets and decentralized finance (“DeFi”). As the first Nasdaq-listed digital asset manager of its kind, DeFi Technologies offers equity investors diversified exposure to the broader decentralized economy through its integrated and scalable business model. This includes Valour, which offers access to one hundred of the world’s most innovative digital assets via regulated ETPs; Stillman Digital, a digital asset prime brokerage focused on institutional-grade execution and custody; Reflexivity Research, which provides leading research into the digital asset space; Neuronomics, which develops quantitative trading strategies and infrastructure; and DeFi Alpha, the Company’s internal arbitrage and trading business line. With deep expertise across capital markets and emerging technologies, DeFi Technologies is building the institutional gateway to the future of finance. Follow DeFi Technologies on LinkedIn and X/Twitter, and for more details, visit https://defi.tech/ 

DeFi Technologies Subsidiaries

About Valour
Valour Inc. and Valour Digital Securities Limited (together, “Valour“) issues exchange traded products (“ETPs”) that enable retail and institutional investors to access digital assets in a simple and secure way via their traditional bank account. Valour is part of the asset management business line of DeFi Technologies. For more information about Valour, to subscribe, or to receive updates, visit valour.com. 

About Stillman Digital
Stillman Digital is a leading digital asset liquidity provider that offers limitless liquidity solutions for businesses, focusing on industry-leading trade execution, settlement, and technology. For more information, please visit https://www.stillmandigital.com

About Reflexivity Research
Reflexivity Research LLC is a leading research firm specializing in the creation of high-quality, in-depth research reports for the bitcoin and digital asset industry, empowering investors with valuable insights. For more information please visit https://www.reflexivityresearch.com/


Cautionary note regarding forward-looking information:

 
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Forward-looking information includes, but is not limited to appointment of directors and officers and other non-executive positions; investor confidence in digital assets generally; the regulatory environment with respect to the growth and adoption of decentralized finance; the pursuit by the Company and its subsidiaries of business opportunities; and the merits or potential returns of any such opportunities. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company, as the case may be, to be materially different from those expressed or implied by such forward-looking information. Such risks, uncertainties and other factors include, but is not limited the acceptance of Valour exchange traded products by exchanges; growth and development of decentralised finance and digital asset sector; rules and regulations with respect to decentralised finance and digital assets; fluctuation in digital asset prices; general business, economic, competitive, political and social uncertainties. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.

THE CBOE CANADA EXCHANGE DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE

Logo – https://mma.prnewswire.com/media/2824423/DeFi_Technologies_Inc__DeFi_Technologies_Announces_Leadership_Tr.jpg

Cision View original content:https://www.prnewswire.com/de/pressemitteilungen/defi-technologies-announces-leadership-transition-olivier-roussy-newton-resigns-as-ceo-and-chairman-co-founder-johan-wattenstrom-appointed-as-successor-302617123.html

rt.gif?NewsItemId=EN25937&Transmission_Id=202511170807PR_NEWS_EURO_ND__EN25937&DateId=20251117

17.11.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News – a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News



Source link

Read More
17 11, 2025

XAG/USD jumps to near $51.00 amid uncertainty after the shutdown ends

By |2025-11-17T16:11:19+02:00November 17, 2025|Forex News, News|0 Comments


Silver price (XAG/USD) trades in positive territory near $51.00 during the Asian trading hours on Monday. The white metal edges higher amid uncertainty following the end of the US government’s shutdown. Federal Reserve officials are set to speak later on Monday, including John Williams, Philip Jefferson, Neel Kashkari and Christopher Waller.

Markets are bracing for a flood of delayed economic reports that could signal a slowing US economy. The US Nonfarm Payrolls (NFP) will take center stage later on Thursday. This report could offer clarity to the Fed rate outlook in December. Any signs of weakness in the US labor market could drag the US Dollar (USD) lower and underpin the USD-denominated commodity price. 

“I think the risk is definitely skewed to a weaker payrolls print, and that would just reignite market expectations about a December FOMC rate cut and send the U.S. dollar down,” said Carol Kong, a currency strategist at Commonwealth Bank of Australia (CBA).

On the other hand, hawkish remarks from Fed policymakers ahead of a deluge of US economic data spooked traders and could weigh on the white metal. Kansas City Fed President Jeffery Schmid said on Friday that monetary policy should lean against demand growth, adding that current Fed policy is “modestly restrictive,” which he believes is appropriate. 

Markets are now pricing in nearly a 40% possibility of a 25 basis points (bps) rate cut in the Fed’s December meeting, down from over 60% earlier this month, according to the CME FedWatch tool. 

Silver FAQs

Silver is a precious metal highly traded among investors. It has been historically used as a store of value and a medium of exchange. Although less popular than Gold, traders may turn to Silver to diversify their investment portfolio, for its intrinsic value or as a potential hedge during high-inflation periods. Investors can buy physical Silver, in coins or in bars, or trade it through vehicles such as Exchange Traded Funds, which track its price on international markets.

Silver prices can move due to a wide range of factors. Geopolitical instability or fears of a deep recession can make Silver price escalate due to its safe-haven status, although to a lesser extent than Gold’s. As a yieldless asset, Silver tends to rise with lower interest rates. Its moves also depend on how the US Dollar (USD) behaves as the asset is priced in dollars (XAG/USD). A strong Dollar tends to keep the price of Silver at bay, whereas a weaker Dollar is likely to propel prices up. Other factors such as investment demand, mining supply – Silver is much more abundant than Gold – and recycling rates can also affect prices.

Silver is widely used in industry, particularly in sectors such as electronics or solar energy, as it has one of the highest electric conductivity of all metals – more than Copper and Gold. A surge in demand can increase prices, while a decline tends to lower them. Dynamics in the US, Chinese and Indian economies can also contribute to price swings: for the US and particularly China, their big industrial sectors use Silver in various processes; in India, consumers’ demand for the precious metal for jewellery also plays a key role in setting prices.

Silver prices tend to follow Gold’s moves. When Gold prices rise, Silver typically follows suit, as their status as safe-haven assets is similar. The Gold/Silver ratio, which shows the number of ounces of Silver needed to equal the value of one ounce of Gold, may help to determine the relative valuation between both metals. Some investors may consider a high ratio as an indicator that Silver is undervalued, or Gold is overvalued. On the contrary, a low ratio might suggest that Gold is undervalued relative to Silver.



Source link

Read More
Go to Top